Quick Answer
ADMA BIOLOGICS, INC. reported Total Assets of $624.24 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed an increase of +27.7% in Total Assets from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $8.5 thousand | Q3 2011: $5.9 thousand | Q1 2012: $17.01 million | Q2 2012: $15.88 million | Q3 2012: $13.22 million | Q1 2013: $13.82 million | Q2 2013: $10.69 million | Q3 2013: $8.70 million | Q1 2014: $31.95 million | Q2 2014: $27.88 million | Q3 2014: $25.29 million | Q1 2015: $33.93 million | Q2 2015: $29.80 million | Q3 2015: $27.82 million | Q1 2016: $19.68 million | Q2 2016: $31.74 million | Q3 2016: $27.50 million | Q1 2017: $17.59 million | Q2 2017: $84.64 million | Q3 2017: $72.81 million | Q1 2018: $91.14 million | Q2 2018: $117.75 million | Q3 2018: $106.35 million | Q1 2019: $78.12 million | Q2 2019: $143.27 million | Q3 2019: $137.78 million | Q1 2020: $210.52 million | Q2 2020: $191.54 million | Q3 2020: $189.98 million | Q1 2021: $235.67 million | Q2 2021: $232.81 million | Q3 2021: $238.64 million | Q1 2022: $308.03 million | Q2 2022: $296.93 million | Q3 2022: $300.56 million | Q1 2023: $340.79 million | Q2 2023: $343.03 million | Q3 2023: $349.00 million | Q1 2024: $350.88 million | Q2 2024: $376.40 million | Q3 2024: $390.62 million | Q1 2025: $510.57 million | Q2 2025: $558.38 million | Q3 2025: $568.69 million.
- Over the full 15 years of available data (2011 to 2025), ADMA BIOLOGICS, INC.'s Total Assets has grown by 21,235.0%.
- Historical annual values: Fiscal year 2025: $624.24 million | Fiscal year 2024: $488.68 million | Fiscal year 2023: $329.18 million | Fiscal year 2022: $348.46 million | Fiscal year 2021: $276.25 million | Fiscal year 2020: $207.67 million | Fiscal year 2019: $127.09 million | Fiscal year 2018: $88.88 million | Fiscal year 2017: $108.02 million | Fiscal year 2016: $23.69 million | Fiscal year 2015: $23.71 million | Fiscal year 2014: $27.02 million | Fiscal year 2013: $31.98 million | Fiscal year 2012: $15.56 million | Fiscal year 2011: $2.93 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: